ProCE Banner Activity


Spinal Muscular Atrophy: Improved Recognition and Management of a Rare Disease

Podcast Episodes

Drs. Julie Parsons and Vanessa Battista discuss the recognition and initial management of spinal muscular atrophy (SMA) at the time of diagnosis.

Physician Assistants/Physician Associates: 0.25 AAPA Category 1 CME credit

Nurse Practitioners: 0.25 Nursing contact hours, includes 0.25 hour of pharmacotherapy credit

Released: April 18, 2023

Expiration: April 17, 2024

No longer available for credit.



Vanessa Battista

Vanessa Battista, DNP, MBA, RN, MS, CPNP-PC, CHPPN, FPCN

Senior Director of Nursing, Palliative Care
Psychosocial Oncology and Palliative Care
Boston, Massachusetts

Julie Parsons

Julie Parsons, MD

Professor of Clinical Pediatrics and Neurology
University of Colorado 
Aurora, Colorado 

Provided by

Provided by Partners for Advancing Clinical Education (PACE)

ProCE Banner


Supported by an educational grant from Biogen


Target Audience

NPs and PAs who care for patients with spinal muscular atrophy (SMA).

Program Learning Goal

The goal of this activity is to improve the knowledge and competence of NPs and PAs so they can confidently and competently apply the recent improvements in SMA management to optimize patient outcomes.

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Explain the rationale for early initiation of treatment in SMA


All faculty and planners participating in continuing education activities sponsored by Partners for Advancing Clinical Education (PACE) are required to disclose all financial relationships with ineligible companies. All relevant conflicts of interest are thoroughly vetted and mitigated according to PACE policy. In addition, all faculty are required to openly disclose any off-label, experimental, or investigational use of drugs or devices discussed in this activity. The faculty and Planning Committee have been advised that this activity must be free from commercial bias and based upon all available scientifically rigorous data from research that conforms to accepted standards of experimental design, data collection, and analysis.

The faculty reported the following relevant financial relationships or relationships to products or devices they have with ineligible companies related to the content of this educational activity:

Primary Author

Vanessa Battista, DNP, MBA, RN, MS, CPNP-PC, CHPPN, FPCN

Senior Director of Nursing, Palliative Care
Psychosocial Oncology and Palliative Care
Boston, Massachusetts

Vanessa Battista, DNP, MBA, RN, MS, CPNP-PC, CHPPN, FPCN: consultant/advisor/speaker: Biogen, Novartis.

Julie Parsons, MD

Professor of Clinical Pediatrics and Neurology
University of Colorado 
Aurora, Colorado 

Julie A. Parsons, MD: consultant/advisor/speaker: Biogen, Genentech, Novartis, Scholar Rock.

The planners and content peer reviewers from Partners for Advancing Clinical Education and Practicing Clinicians Exchange do not have any relevant financial relationships to disclose.

Instructions for Credit

Participation in this self-study activity should be completed in approximately 0.25 hours. To successfully complete this activity and receive credit, learners must follow these steps during the period from April 18, 2023, through April 17, 2024:

1. Login or Sign Up for an account by clicking at the top of this page.
2. Read the target audience, learning objectives, and faculty disclosures.
3. View and study the content in its entirety.
4. Submit answers to the posttest questions and evaluation questions online.

You must receive a test score of at least 65% and respond to all evaluation questions to receive a certificate. After submitting the evaluation, you may access your online certificate by selecting the certificate link on the confirmation page. Records of all CME/CE activities completed can be found on the "My Certificates" page. There are no costs/fees for this activity.


This program has been made available online.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.


The opinions or views expressed in this CE/CME activity do not necessarily reflect the opinions or recommendations of Partners for Advancing Clinical Education, Practicing Clinicians Exchange, or any educational supporter.


Joint Accreditation Statement
Joint AccreditationIn support of improving patient care, Partners for Advancing Clinical Education (PACE) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team. 

ANCC Credit Designation
The maximum number of hours awarded for this Nursing Continuing Professional Development activity is 0.25 contact hours, including 0.25 hours of pharmacology credit.

AAPA Credit Designation
Joint AccreditationPartners for Advancing Clinical Education (PACE) has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 0.25 AAPA Category 1 CME credits. Approval is valid until April 17, 2024. PAs should only claim credit commensurate with the extent of their participation. 

IPCE Credit Designation

This activity was planned by and for the healthcare team, and learners will receive 0.25 Interprofessional Continuing Education (IPCE) credits for learning and change.